They are an invaluable tool. Experts turn to unexpected helpers for critical mission in 'tortoise capital of the world' — ...

Ocugen has a valuable IP portfolio, which should give it funding options. OCGN’s cash runway remains the main risk. Check out what makes OCGN worth a Buy.

Alberta Health Services (AHS) has issued multiple warnings over Wednesday and Thursday about possible measles exposure at ...

Think you need 8 cups of water a day? Or that coffee dehydrates you? Experts debunk the most common misconceptions about ...

The clinical trial support services market is experiencing significant growth, driven by the increasing incidence of chronic illnesses such as cancer ...

A new twice-yearly antiviral injection that can prevent HIV is likely to be approved soon in Australia. Making it affordable ...

Amid declining vaccination rates in Australia, a new strategy seeks to reduce vaccine hesitancy and improve access to immunisations.

HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...

The federal government has revealed plans to tackle declining childhood vaccination rates with the launch of a new immunisation plan.

Explore the latest on VYVGART HYTRULO's FDA safety signal and transition challenges. Learn why argenx's balanced risks keep ...

On any given summer day, 38,000 commuter cars inch across the Shinnecock Canal, and past the oldest Hamptonite: a ...